Implantation of an Adjustable Suburethral Sling is an Effective Treatment Method for Patients With Mixed Urinary Incontinence of Moderate to Severe Severity, After Which the Severity of the Stress and Urgency Components is Reduced.

Optimizing the Management of Patients With Mixed Urinary Incontinence.

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07564323

Enrollment

156

Registered

2026-05-04

Start date

2026-04-24

Completion date

2028-04-24

Last updated

2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mixed Urinary Incontinence

Keywords

mixed urinary incontinence, adjustable suburethral sling

Brief summary

The aim of this clinical study is to optimize treatment outcomes in patients with mixed forms of urinary incontinence by implanting an adjustable suburethral sling and to determine factors influencing treatment effectiveness. The main questions it aims to answer are: 1. What is the effectiveness of an adjustable suburethral sling in patients with mixed urinary incontinence? 2. How do preoperative medications and other factors affect the effectiveness of adjustable suburethral sling implantation? 3. How does quality of life change in these patients after surgery? Participants will undergo implantation of an adjustable suburethral sling. Postoperatively, the effectiveness of the sling for mixed urinary incontinence will be assessed. Predictors of treatment effectiveness will also be identified. Patients will be examined 24 hours after surgery, 2 months later, and 1 year later.

Interventions

PROCEDUREimplantation of an adjustable suburethral sling

Surgical access will be achieved through the anterior vaginal wall, projecting toward the middle third of the urethra. The UroSling endoprosthesis will be inserted using the standard technique.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Women over 18 years of age. * Mixed urinary incontinence (stress and urgency components, with the stress component being predominant or equal) of moderate to severe severity, confirmed by questionnaire data. * Signed informed consent to participate in the study.

Exclusion criteria

* Isolated stress or urge urinary incontinence. * Contraindications to diagnosis and treatment. * Obstructive urination, large residual urine volume. * Chronic pelvic pain syndrome. * Pelvic organ prolapse (grade 2 or higher according to POP-Q). * History of any suburethral sling implantation. * History of surgical treatment for pelvic organ prolapse. * Pregnancy.

Design outcomes

Primary

Measure	Time frame	Description
The Overactive Bladder Symptom Score (OABSS) questionnaire	At 24 hours postoperatively compared	Changes in scores on the Overactive Bladder Symptom Score (OABSS) questionnaire at 24 hours postoperatively compared to pre-treatment values.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026